Tumor Burden and Intraosseous Metabolic Activity as Predictors of Bone Marrow Failure during Radioisotope Therapy in Metastasized Prostate Cancer Patients

<div>Mean counts in <svg height="12.584pt" id="M60" style="vertical-align:-3.29567pt" version="1.1" viewbox="-0.0498162 -9.28833 51.9624 12.584" width="51.9624pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M578 512C578 619 494 650 387 650H140L134 622C219 615 223 609 210 542L127 119C112 40 104 34 23 28L17 0H235C317 0 387 7 444 33C515 65 564 122 564 195C564 289 495 335 412 352V354C505 373 578 422 578 512ZM486 510C486 422 423 367 314 367H257L294 565C299 591 305 602 315 608C324 614 339 617 362 617C421 617 486 595 486 510ZM466 200C466 100 393 35 296 35C222 35 198 51 212 127L250 333H303C388 333 466 303 466 200Z" id="g113-67"></path></g><g transform="matrix(.0091,0,0,-0.0091,7.748,3.132)"><path d="M698 650H468V617C551 609 555 599 536 543C506 457 432 264 379 129H377C311 297 238 488 212 560C196 604 198 609 271 617V650H21V617C80 612 98 603 127 532C183 396 268 173 335 -9H370C445 196 551 450 578 511C615 602 630 609 698 617V650Z" id="g58-84"></path></g><g transform="matrix(.0091,0,0,-0.0091,13.396,3.132)"><path d="M262 451C169 451 38 375 38 210C38 98 121 -12 261 -12C360 -12 481 64 481 227C481 351 386 451 262 451ZM249 414C337 414 385 320 385 204C385 70 333 25 272 25C189 25 134 117 134 241C134 355 189 414 249 414Z" id="g58-109"></path></g><g transform="matrix(.0091,0,0,-0.0091,18.055,3.132)"><path d="M244 0V30C178 35 170 41 170 107V710C136 697 72 680 18 675V647C83 642 89 639 89 572V107C89 43 80 35 16 30V0H244Z" id="g58-106"></path></g><g transform="matrix(.013,0,0,-0.013,20.97,0)"><path d="M368 703H309L44 -163H104L368 703Z" id="g113-48"></path></g><g transform="matrix(.013,0,0,-0.013,26.331,0)"><path d="M962 650H795L470 145L347 650H176L170 622C268 613 275 606 244 503L190 322C150 188 132 126 118 91C102 50 80 33 18 28L12 0H245L251 28C175 35 170 48 174 93C177 128 191 180 220 284L292 542H294C331 392 383 150 409 4H432L774 555H776L714 137C700 40 694 34 612 28L606 0H868L874 28C793 34 784 37 797 137L849 533C859 612 863 616 956 622L962 650Z" id="g113-78"></path></g><g transform="matrix(.0091,0,0,-0.0091,38.551,3.132)"><path d="M698 650H468V617C551 609 555 599 536 543C506 457 432 264 379 129H377C311 297 238 488 212 560C196 604 198 609 271 617V650H21V617C80 612 98 603 127 532C183 396 268 173 335 -9H370C445 196 551 450 578 511C615 602 630 609 698 617V650Z" id="g58-84"></path></g><g transform="matrix(.0091,0,0,-0.0091,44.199,3.132)"><path d="M262 451C169 451 38 375 38 210C38 98 121 -12 261 -12C360 -12 481 64 481 227C481 351 386 451 262 451ZM249 414C337 414 385 320 385 204C385 70 333 25 272 25C189 25 134 117 134 241C134 355 189 414 249 414Z" id="g58-109"></path></g><g transform="matrix(.0091,0,0,-0.0091,48.858,3.132)"><path d="M244 0V30C178 35 170 41 170 107V710C136 697 72 680 18 675V647C83 642 89 639 89 572V107C89 43 80 35 16 30V0H244Z" id="g58-106"></path></g></svg> in whole-body, axial, and appendicular skeleton.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Tumor Burden and Intraosseous Metabolic Activity as Predictors of Bone Marrow Failure during Radioisotope Therapy in Metastasized Prostate Cancer Patients 

Figure 2 | Tumor Burden and Intraosseous Metabolic Activity as Predictors of Bone Marrow Failure during Radioisotope Therapy in Metastasized Prostate Cancer Patients 